Chemical Substances
www.chemicalsubstances.gc.ca
Common menu bar links
Hexabromocyclododecane (HBCD)
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
- Adding Substances to Schedule 1 of the Canadian Environmental Protection Act
- Final Screening Assessment and Proposed Risk Management Approach
- Draft Screening Assessment and Risk Management Scope
Adding Substances to Schedule 1 of the Canadian Environmental Protection Act
Hexabromocyclododecane (HBCD) was determined to meet one or more of the criteria in section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999) and therefore was proposed to be added to Schedule 1.
- Proposed Order adding HBCD:
Canada Gazette, Part I, Vol. 145, No. 50 – December 10, 2011 ( PDF Version - 1694 K)
Final Screening Assessment and Proposed Risk Management Approach
In November 2011, the Final Screening Assessment Report on Hexabromocyclododecane (HBCD) was released and the relating Notice was published in the Canada Gazette, Part I, Vol. 145, No. 46 - November 12, 2011 ( PDF Version - 1191 K).
The final screening assessment concludes that:
- HBCD meets one or more of the criteria set out in section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999);
- HBCD meets the criteria for persistence and bioaccumulation potential out in the Persistence and Bioaccumulation Regulations.
A proposed Risk Management Approach Document on Hexabromocyclododecane (HBCD) was also released on this date. This document builds on the previously released risk management scope document, and outlines, in more depth, the risk management actions for this substance, including the choice of risk management instruments. There is a 60-day public comment period on the proposed risk management approach document, from November 12, 2011 to January 11, 2012. Information on how to submit comments is provided in the proposed risk management approach document.
Draft Screening Assessment and Risk Management Scope
In August 2010, the draft screening assessment on hexabromocyclododecane (HBCD) was released and the related Notice was published in the (Canada Gazette Part I, Vol. 144 No. 35 - August 28, 2010) ( PDF Version - 2179 K) for a 60 day public comment period. A risk management scope document was also released on this date.
The public comments received have been considered and addressed within the final screening assessment report, and a Summary Table of Public Comments Received on the Draft Screening Assessment Report on Hexabromocyclododecane (HBCD) is now available.
If you have questions or comments, please contact us.
